Corporate ActionJun 5, 2026, 04:24 PM
Unicycive Therapeutics Increases ATM Offering to $150M
AI Summary
Unicycive Therapeutics, Inc. announced an increase in its at-the-market (ATM) offering capacity. The company amended its Sales Agreement with Guggenheim Securities, LLC to raise the aggregate offering price for its common stock to up to $150,000,000, an increase of $50,000,000. This capital raise is facilitated through an ATM offering, with a corresponding Shelf Registration Statement on Form S-3 filed with the SEC.
Key Highlights
- Unicycive Therapeutics increased its at-the-market (ATM) offering capacity by $50,000,000.
- The total aggregate offering price for the ATM offering is now up to $150,000,000.
- The company previously had an ATM offering capacity of up to $100,000,000.
- The amendment to the Sales Agreement was made with Guggenheim Securities, LLC on June 5, 2026.
- A Shelf Registration Statement on Form S-3 was filed for the additional $50,000,000 in shares.
Price Impact
More from UNCY